| Patient Education |
|
Click here for patient education.
|
|
You are in: eMedicine Specialties >
Allergy and Immunology > Asthma
Vocal Cord Dysfunction
Article Last Updated: May 18, 2006
AUTHOR AND EDITOR INFORMATION
Section 1 of 11  
Author: Praveen Buddiga, MD, Consulting Staff, Allergy, Asthma and Clinical Immunology, Baz Allergy, Asthma and Sinus Center
Praveen Buddiga is a member of the following medical societies: American Academy of Allergy Asthma and Immunology, American College of Allergy, Asthma and Immunology, and American Medical Association
Editors: Richard F Lockey, MD, University Distinguished Health Professor, Professor of Medicine, Pediatrics and Public Health, Joy McCann Culverhouse Chair in Allergy and Immunology, University of South Florida College of Medicine; Director, Division of Allergy and Immunology, James A Haley Veterans' Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Michael R Simon, MD, MA, Professor, Departments of Pediatrics and Internal Medicine, Wayne State University School of Medicine; Consulting Staff, Department of Allergy and Immunology, Henry Ford Health System; Timothy D Rice, MD, Associate Professor, Departments of Internal Medicine and Pediatrics and Adolescent Medicine, Saint Louis University School of Medicine; Michael A Kaliner, MD, Clinical Professor of Medicine, George Washington University School of Medicine; Chief, Section of Allergy and Immunology, Washington Hospital Center; Medical Director, Institute for Asthma and Allergy
Author and Editor Disclosure
Synonyms and related keywords:
vocal cord dysfunction, VCD, paradoxical vocal cord motion, laryngeal dyskinesia, abnormal adduction of the vocal cords during the respiratory cycle, airflow obstruction, variable extrathoracic obstruction, inspiratory loop flattening, depression, obsessive-compulsive disorder, borderline personality disorder, neuroses induced by childhood sexual abuse, asthma
Background
Vocal cord dysfunction (VCD) can be characterized as an abnormal adduction of the vocal cords during the respiratory cycle (especially during the inspiratory phase) that produces airflow obstruction at the level of the larynx.
VCD frequently mimics persistent asthma and is often treated with high-dose inhaled and/or systemic corticosteroids, bronchodilators, multiple emergency department visits, hospitalizations, and in some cases, tracheostomies and intubation.
This subset of patients has problems associated with abnormal vocal cord movement without an organic basis. Flow-volume loops obtained during symptomatic periods of wheezing show a limitation of inspiratory flow suggestive of variable extrathoracic obstruction (inspiratory loop flattening). Paradoxical vocal cord motion can be confirmed on laryngoscopy performed when patients are symptomatic.
The clinical history provides limited opportunity to distinguish between patients with VCD and patients with asthma because both groups present with symptoms of wheezing, cough, and dyspnea. The localization of airflow obstruction to the laryngeal pharynx is an important clinical discriminatory feature with VCD.
Another clinical clue may be that patients with VCD often seem to have refractory asthma with poor response to beta-agonists or inhaled corticosteroids. They do not usually report nocturnal awakening due to breathlessness.
Objectively, the data reveal absence of hypoxemia in this subset as compared to compromised asthmatic persons.
The hallmark of diagnosis is noted on direct rhinolaryngoscopy; a glottic chink is present along the posterior portion of the vocal cords, while the anterior portion of the vocal cords is adducted.
Pathophysiology
During the normal respiratory cycle, the vocal cords partially abduct with inhalation and partially adduct with end-exhalation. This phasic vocal cord movement is physiologic, and it allows the unimpeded movement of air inward to the lungs and outward to the atmosphere while maintaining the alveolar patency of the lungs by providing positive airway pressure during expiration (ie, positive end-expiratory pressure [PEEP]). The larynx therefore serves as an upper airway valve to help keep the lungs expanded. Additionally, the larynx is richly innervated, and its size is regulated by the activation of striated muscles that are under voluntary and reflexive control. Both laryngeal and respiratory motor neurons influence glottic size, as does any reflex activity arising from pulmonary and laryngeal receptors. The mechanism that causes glottic chink narrowing or intermittent closing during inspiration independent of any changes in lower airway caliber are unknown. Nevertheless, the integrated function of the vocal cords ceases episodically, and affected patients develop acute intermittent episodes of functional airway obstruction. These clinical signs and symptoms resemble those observed in disorders such as vocal cord paralysis, asthma, epiglottitis, laryngospasm, and angioedema secondary to anaphylaxis. Recent case reports have shown other causes of vocal cord dysfunction, such as an inlet patch of heterotopic gastric mucosa in the upper esophagus and exposure to agents such as glutaraldehyde, chlorine, or even eucalyptus. To summarize, the exact cause of this condition is not clearly evident, but the hypothesis is that mediation of the vagus nerve may alter the laryngeal tone and lower the threshold for stimuli to produce vocal cord spasm or to precipitate the abnormal adduction of vocal cords. Recent literature suggests a greater emphasis on organic causes such as gastroesophageal reflux, laryngopharyngeal reflux, and neurologically-based dystonias.
Frequency
United States
This condition is observed in up to 10% of patients at referral centers seeking evaluation of asthma that is unresponsive to aggressive therapy. The literature reveals a high incidence of VCD in persons with psychiatric conditions (eg, depression, obsessive-compulsive disorder, borderline personality disorder, neuroses induced by childhood sexual abuse), persons with an increased body mass index and medical personnel. VCD may complicate true asthma in a small number of patients.
Mortality/Morbidity
Mortality rates are unknown, and morbidity is often significant from years of corticosteroid use, resulting in iatrogenic Cushing-like syndrome, bone density loss, and growth suppression in the pediatric population.
Sex
This condition is predominantly observed in young adult females. The authors' review of the published literature indicates a female-to-male ratio of approximately 7:3.
Age
This condition predominates in people aged 20-40 years, but it can occur in people aged 6-83 years. Recent literature suggests an increase of this condition in children and adolescents.
History
- Wheezing
- Cough
- A feeling of tightness in the throat
- Hoarseness and voice change
- Stridor
- Shortness of breath
- Dyspnea on exertion
- Inspiratory difficulty
- Sudden episodes of shortness of breath
- Unresponsiveness to bronchodilators and corticosteroids
Physical
- Laryngeal auscultation may reveal harsh stridulous sounds during symptoms.
- Wheezing may be heard in the chest (transmitted from the upper airway).
Causes
Problems associated with VCD include the following:
- Gastroesophageal reflux disease, laryngopharyngeal reflux
- Sinusitis
- Postnasal drip
- Strenuous exercise
- Occupational exposure to irritant fumes
- Environmental allergens and/or pollutants
- Psychogenic causes
Anaphylaxis
Asthma
Other Problems to be Considered
Laryngeal spasm
Foreign body obstruction
Laryngeal abnormalities (eg, neoplasm, polyp, cyst)
Lab Studies
- Laboratory studies may be indicated to exclude other diagnoses.
- Eosinophil count
- Eosinophilia may suggest the diagnosis of asthma if levels are greater than 5%, but absence of this sign does not clearly exclude the diagnosis, especially if the patient has been frequently treated with oral corticosteroids.
- Elevated eosinophil counts may also be observed in skin diseases such as atopic dermatitis and in clinical entities such as pulmonary infiltrates with eosinophilia, allergic bronchopulmonary aspergillosis (ABPA), Churg-Strauss syndrome, and parasitic diseases.
- VCD, per se, is not associated with an elevated blood eosinophil count.
- Serum immunoglobulin E (IgE) assay
- Elevated serum IgE is observed in allergic individuals, but it is not specific for asthma.
- This elevation may be observed in other syndromes such as ABPA and Churg-Strauss syndrome. Its presence may indicate a concomitant diagnosis of asthma even though its absence is not exclusionary.
- VCD, per se, is not associated with an elevated serum IgE level.
- Arterial blood gases (ABG): ABG findings reveal an alveolar-arterial gradient (ie, the alveolar-arterial oxygen difference), which is a measure of oxygen delivery from the lungs to blood, that is usually within reference ranges in the subset of patients with VCD. In patients with acute asthma, ABG findings may be abnormal, indicative of hypoxemia.
Imaging Studies
- Chest radiography
- Radiographic findings are usually normal, or radiographs may show hyperinflation in asthmatic individuals.
- Chest radiography may be used to evaluate other pulmonary diseases or structural laryngeal and cardiac abnormalities that may explain or support the patient's respiratory symptoms.
Other Tests
- Pulmonary function test
- Spirometric testing supports the diagnosis of VCD in symptomatic individuals. This study is used to identify individuals with asthma or other pulmonary abnormalities, including upper airway obstruction. In patients without coexisting asthma, spirometric findings are usually within the reference range during an episode. If flows are decreased during an episode, forced vital capacity FVC) decreases in tandem with forced expiratory volume in the first second (FEV1), which is not consistent with classic airflow limitation.
- Flow-volume loops are the most useful tool in discriminating between VCD and asthma. Flow-volume loops typically demonstrate inspiratory loop flattening, ie, an inspiratory flow decrease during symptomatic periods suggestive of VCD (see Image 1). In addition, during VCD symptoms, an abrupt drop and rise in the expiratory flow volume loop may be observed in the absence of coughing.
- Results of routine measurement of airflow obstruction (ie, FEV1, peak expiratory flow rate) can be within reference ranges in VCD if the vocal cords close only on inspiration. If vocal cord closure occurs during both inspiration and expiration, FEV1 can decrease along with the decrease in FVC, making the FEV1/FVC ratio within the reference range. This distinguishes isolated VCD from VCD concomitant with asthma, in which the FEV1 is proportionately decreased more than the FVC, representing airflow limitation.
- Methacholine provocation
- A patient with VCD shows no bronchial hyperresponsiveness on methacholine challenge unless he or she has concomitant asthma.
- This challenge is therefore most helpful in excluding the diagnosis of asthma. It may also be helpful in confirming that a patient with VCD has coexisting asthma.
Procedures
- Laryngoscopy
- The criterion standard for the diagnosis of VCD is direct visualization of the paradoxical adduction of the true vocal cords during inspiration.
- The classic textbook picture is the adduction of the anterior two thirds of the vocal cords with a posterior diamond-shaped chink through which air flows during the inspiratory phase (see Image 2).
Medical Care
A multidisciplinary approach with a physician and speech therapist and a psychiatrist, if needed, is usually effective. - Speech therapy
- The mainstays of treatment for VCD involve teaching the patient vocal cord relaxation techniques and breathing exercises. These procedures have been very successful and are used concomitantly with psychological support in difficult cases.
- The role of the speech therapist is to effectively teach and communicate a comprehensive speech therapy plan with appropriate breathing exercises.
- Psychotherapy: The role of the psychiatrist is to implement cognitive behavior psychotherapy or general psychotherapy based upon evaluation of psychiatric and/or personality disorders.
- Helium-oxygen therapy
- This therapy consists of administration of a helium-oxygen mixture (heliox), which is less dense than air and thus reduces the turbulence in the airway during inspiration.
- Heliox administration provides only a short-term benefit, but it may be very helpful in the emergent treatment of acute VCD.
- Botulinum toxin
- An intralaryngeal injection of botulinum toxin relieves symptoms by blocking acetylcholine release at the motor end plate and creating a laryngeal muscle weakness, thus facilitating inspiratory and expiratory airflow.
- Its use is considered experimental, and equivocal reports in the literature illustrate both effectiveness and lack of benefit.
- Panting: This maneuver causes the adducted vocal cords to relax, which increases the glottic aperture.
- Topical lidocaine
- This may be applied to the larynx.
- The mechanism of action is to break the cycle of hyperactive glottal and supraglottal muscle contractions.
Consultations
- Otolaryngologist
- Pulmonologist
- Allergist and/or immunologist
- Speech therapist
- Psychiatrist
Diet
No diet restrictions are necessary.
No specific pharmacotherapy is indicated.
Further Outpatient Care
- Patients must receive further care to determine the response to patient education and speech therapy and to assess the need for referral for psychiatric care.
Deterrence/Prevention
- Deterrence and prevention can be achieved by adherence to speech therapy guidelines and exercises and by relaxation therapy or other measures to decrease anxiety.
Prognosis
- Prognosis is good with effective response to speech therapy, which allows patients to take control of their disorder.
Patient Education
- Patient education ideally uses a multidisciplinary approach with involvement of a physician and speech therapist and, if needed, a psychiatrist.
- The physician's role is to inform the patient of test findings, especially the absence of diseases such as asthma, and to explain the nature of the condition. Patients often express a positive reaction to the initial explanation, and such a reaction usually implies a good prognosis.
- Online patient educational sources
Medical/Legal Pitfalls
- Failure to recognize coexisting asthma or to recall that VCD is a diagnosis of exclusion
- Failure to recognize functional causes of upper airway obstruction (eg, other pulmonary, cardiac, and structural laryngeal abnormalities) that must be excluded because they may be the etiology of the patient's respiratory symptoms
- Failure to recognize the following organic causes or associated problems, which must be excluded:
- Brain stem compression
- Upper and/or lower motor neuron injury
- Gastroesophageal reflux
- Asthma
- Foreign body obstruction
- Anaphylaxis
Special Concerns
- Early diagnosis of VCD prevents adverse effects of unnecessary and ineffective antiasthmatic therapy (especially corticosteroids).
- Larger population trials are needed to further delineate the true incidence of VCD that is mistaken for asthma because the data in the authors' review indicate that VCD is more common than previously perceived.
- Allan PF, Abouchahine S, Harvis L, Morris MJ. Progressive Vocal Cord Dysfunction Subsequent to a Chlorine Gas Exposure. J Voice. Nov 14 2005;[Medline].
- Anbar RD, Hehir DA. Hypnosis as a diagnostic modality for vocal cord dysfunction. Pediatrics. Dec 2000;106(6):E81. [Medline].
- Bahrainwala AH, Simon MR, Harrison DD, et al. Atypical expiratory flow volume curve in an asthmatic patient with vocal cord dysfunction. Ann Allergy Asthma Immunol. Apr 2001;86(4):439-43. [Medline].
- Bahrainwala AH, Simon MR. Wheezing and vocal cord dysfunction mimicking asthma. Curr Opin Pulm Med. Jan 2001;7(1):8-13. [Medline].
- Brancatisano T, Collett PW, Engel LA. Respiratory movements of the vocal cords. J Appl Physiol. May 1983;54(5):1269-76. [Medline].
- Byrd RP Jr, Krishnaswamy G, Roy TM. Difficult-to-manage asthma. How to pinpoint the exacerbating factors. Postgrad Med. Nov 2000;108(6):37-40, 45-6, 49-50 passim. [Medline].
- Christopher KL, Wood RP 2nd, Eckert RC, et al. Vocal-cord dysfunction presenting as asthma. N Engl J Med. Jun 30 1983;308(26):1566-70. [Medline].
- Diamond E, Kane C, Dugan G. Presentation and Evaluation of Vocal Cord Dysfunction. Chest. 2000;118(Suppl 4):199S.
- Dworkin JP, Meleca RJ, Simpson ML, Garfield I. Use of topical lidocaine in the treatment of muscle tension dysphonia. J Voice. Dec 2000;14(4):567-74. [Medline].
- Freedman MR, Rosenberg SJ, Schmaling KB. Childhood sexual abuse in patients with paradoxical vocal cord dysfunction. J Nerv Ment Dis. May 1991;179(5):295-8. [Medline].
- Galdi E, Perfetti L, Pagella F, et al. Irritant vocal cord dysfunction at first misdiagnosed as reactive airway dysfunction syndrome. Scand J Work Environ Health. Jun 2005;31(3):224-6. [Medline].
- Goldman J, Muers M. Vocal cord dysfunction and wheezing. Thorax. Jun 1991;46(6):401-4. [Medline].
- Grillone GA, Blitzer A, Brin MF, et al. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope. Jan 1994;104(1 Pt 1):30-2. [Medline].
- Hayes JP, Nolan MT, Brennan N, FitzGerald MX. Three cases of paradoxical vocal cord adduction followed up over a 10- year period. Chest. Sep 1993;104(3):678-80. [Medline].
- Higgins JC. The ''crashing astimatic.''. Am Fam Physician. Mar 1 2003;67(5):997-1004. [Medline].
- Huggins JT, Kaplan A, Martin-Harris B, Sahn SA. Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. Sep 2004;93(3):299-303. [Medline].
- Jain S, Bandi V, Zimmerman J, et al. Incidence of Vocal Cord Dysfunction in Patients Presenting to Emergency Room with Acute Asthma Exacerbation. Chest. 1999;116(Suppl 4):243S.
- Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest. Mar 1995;107(3):757-60. [Medline].
- Landwehr LP, Wood RP 2nd, Blager FB, Milgrom H. Vocal cord dysfunction mimicking exercise-induced bronchospasm in adolescents. Pediatrics. Nov 1996;98(5):971-4. [Medline].
- Link HW, Stillwell PC, Jensen VK, Laskowski DM. Vocal Cord Dysfunction in the Pediatric Age Group. Chest. 1998;114(Suppl 4):255S-256S.
- Maillard I, Schweizer V, Broccard A, et al. Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement. Chest. Sep 2000;118(3):874-7. [Medline].
- Manthous CA, Hall JB, Caputo MA, et al. Heliox improves pulsus paradoxus and peak expiratory flow in nonintubated patients with severe asthma. Am J Respir Crit Care Med. Feb 1995;151(2 Pt 1):310-4. [Medline].
- Martin R, Blager F, Gay M, et al. Paradoxical vocal cord motion in presumed asthmatics. Semin Respir Med. 1987;8:332-337.
- Maschka DA, Bauman NM, McCray PB Jr, et al. A classification scheme for paradoxical vocal cord motion. Laryngoscope. Nov 1997;107(11 Pt 1):1429-35. [Medline].
- McFadden ER Jr. Glottic function and dysfunction. J Allergy Clin Immunol. May 1987;79(5):707-10. [Medline].
- McFadden ER Jr, Zawadski DK. Vocal cord dysfunction masquerading as exercise-induced asthma. a physiologic cause for "choking" during athletic activities. Am J Respir Crit Care Med. Mar 1996;153(3):942-7. [Medline].
- Morris MJ, Deal LE, Bean DR, et al. Vocal cord dysfunction in patients with exertional dyspnea. Chest. Dec 1999;116(6):1676-82. [Medline].
- Murray DM, Lawler PG. All that wheezes is not asthma. Paradoxical vocal cord movement presenting as severe acute asthma requiring ventilatory support. Anaesthesia. Oct 1998;53(10):1006-11. [Medline].
- Newman KB, Dubester SN. Vocal Cord Dysfunction: Masquerader of Asthma. Semin Resp Crit Care Med. 1994;15:161-167.
- Newman KB, Mason UG 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med. Oct 1995;152(4 Pt 1):1382-6. [Medline].
- O''Connell MA, Sklarew PR, Goodman DL. Spectrum of presentation of paradoxical vocal cord motion in ambulatory patients. Ann Allergy Asthma Immunol. Apr 1995;74(4):341-4. [Medline].
- O''Hollaren MT. Masqueraders in clinical allergy: laryngeal dysfunction causing dyspnea. Ann Allergy. Nov 1990;65(5):351-6. [Medline].
- Paparella MM, Shumrick D, Gluckman J, Meyerhoff W. Otolaryngology: Head & Neck. 3rd ed. Philadelphia, Pa:. WB Saunders Co;1991.
- Parker JM, Mooney LD, Berg BW. Exercise Tidal Loops in Patients with Vocal Cord Dysfunction. Chest. 1998;114(Suppl 4):256S.
- Patterson DL, O'Connell EJ. Vocal Cord Dysfunction: What have we learned in 150 years?. Insights in Allergy. 1994;9(6):1-12.
- Perkner JJ, Fennelly KP, Balkissoon R, et al. Irritant-associated vocal cord dysfunction. J Occup Environ Med. Feb 1998;40(2):136-43. [Medline].
- Powell DM, Karanfilov BI, Beechler KB, et al. Paradoxical vocal cord dysfunction in juveniles. Arch Otolaryngol Head Neck Surg. Jan 2000;126(1):29-34. [Medline].
- Reisner C, Nelson HS. Vocal cord dysfunction with nocturnal awakening. J Allergy Clin Immunol. Jun 1997;99(6 Pt 1):843-6. [Medline].
- Sandage MJ, Zelazny SK. Paradoxical vocal fold motion in children and adolescents. Lang Speech Hear Serv Sch. Oct 2004;35(4):353-62. [Medline].
- Schachter AJ. Vocal cord dysfunction may be functional. Chest. Jul 1998;114(1):351. [Medline].
- Selner JC, Staudenmayer H, Koepke JW, et al. Vocal cord dysfunction: the importance of psychologic factors and provocation challenge testing. J Allergy Clin Immunol. May 1987;79(5):726-33. [Medline].
- Silvers WS, Levine JS, Poole JA, et al. Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction. Ann Allergy Asthma Immunol. Jan 2006;96(1):112-5. [Medline].
- Sokol W. Vocal cord dysfunction presenting as asthma. West J Med. Jun 1993;158(6):614-5. [Medline].
- Soli CG, Smally AJ. Vocal cord dysfunction: an uncommon cause of stridor. J Emerg Med. Jan 2005;28(1):31-3. [Medline].
- Vlahakis NE, Patel AM, Maragos NE, Beck KC. Diagnosis of vocal cord dysfunction: the utility of spirometry and plethysmography. Chest. Dec 2002;122(6):2246-9. [Medline].
- Weir M, Ehl L. Vocal cord dysfunction mimicking exercise-induced bronchospasm in adolescents. Pediatrics. Jun 1997;99(6):923-4. [Medline].
- Wood RP 2nd, Milgrom H. Vocal cord dysfunction. J Allergy Clin Immunol. Sep 1996;98(3):481-5. [Medline].
Vocal Cord Dysfunction excerpt Article Last Updated: May 18, 2006
|
